OS | DFS | PFS | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Variables | N=97 | HR | 95%CI | p | N=93 | HR | 95%CI | p | N=97 | HR | 95%CI | p |
Univariate analysis | ||||||||||||
Age | ||||||||||||
<65 vs ≥65 | 103 | 1.23 | 0.46-3.28 | 0.68 | 93 | 1.06 | 0.41-2.75 | 0.90 | 102 | 1.37 | 0.49-3.79 | 0.54 |
FIGO stage | ||||||||||||
III-IV vs I-II | 97 | 17.05 | 5.47-53.17 | <0.01 | 93 | 5.88 | 2.25-15.34 | <0.01 | 96 | 16.73 | 5.28-53.03 | <0.01 |
Tumor grade | ||||||||||||
G1 vs G2-G3 | 103 | 0.001 | -* | 0.68 | 99 | 0.155 | 0.02-1.18 | 0.07 | 102 | 0.001 | -* | 0.69 |
Lymph node involvement | ||||||||||||
positive vs negative | 87 | 10.17 | 3.22-32.11 | <0.01 | 85 | 6.05 | 2.09-17.51 | <0.01 | 86 | 14.07 | 4.08-48.49 | <0.01 |
Trop-2 IHC | ||||||||||||
score=3 vs score 0/1/2 | 103 | 2.60 | 0.94-7.19 | 0.06 | 99 | 3.36 | 1.26-8.92 | 0.01 | 102 | 2.80 | 0.99-7.87 | 0.05 |
Multivariate analysis | ||||||||||||
Trop-2 IHC | 97 | 93 | 97 | |||||||||
score=3 vs score 0/1/2 | 1.83 | 0.65-5.18 | 0.25 | 2.82 | 1.05-7.58 | 0.04 | 1.76 | 0.63-4.88 | 0.28 | |||
FIGO stage | 97 | 93 | 97 | |||||||||
III-IV vs I-II | 15.94 | 5.08-50.04 | <0.001 | 5.36 | 2.04-14.08 | <0.001 | 16.73 | 5.31-52.73 | <0.001 |